GMXAYGENMAB A/S/S ADR

$25.05
$0.42
(1.70%)
Today
Closed $25.15
$0.10
(0.40%)
After Hours
Updated: 07:01 PM EDT
Mkt Cap$14.71B
Vol2.09M

About

Genmab A/S is an international biotechnology company, which engages in the development of human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline includes daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma, teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease, and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia. The company was founded by Donald Lee Drakeman, Florian Schonharting, and Jan G. J. van de Winkel on June 11, 1998, and is headquartered in Copenhagen, Denmark.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
3,029

Frequently Asked Questions

What is Market Cap of Genmab - ADR?
What is the 52-week high for Genmab - ADR?
What is the 52-week low for Genmab - ADR?
What is Genmab - ADR stock price today?
What was Genmab - ADR stock price yesterday?
What is the PE ratio of Genmab - ADR?
What is the Price-to-Book ratio of Genmab - ADR?
What is the 50-day moving average of Genmab - ADR?
How many employees does Genmab - ADR have?

Advertisement|Remove ads.